Funded Tech Companies
Arialys Therapeutics
Arialys Therapeutics, operating out of LA JOLLA, received equity investments from Alexandria Venture Investments, Avalon BioVentures and MPM Capital.
Company Overview
Company Name
Arialys Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11099 NORTH TORREY PINES RD 290
LA JOLLA, CA 92037
USA
LA JOLLA, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Arialys Therapeutics, a private biotech company founded by Avalon BioVentures, Catalys Pacific, and MPM Capital, is exploring scientific breakthroughs in autoimmune neurology to develop new precision medicines for autoimmune neuropsychiatric diseases. Our lead therapeutic candidate, ART5803, is being developed as a potential treatment for anti-NMDA receptor encephalitis (ANRE), a life-threatening neurological disease that causes severe psychosis. ART5803 also has potential to treat autoimmune dementia. The Arialys team has decades of experience identifying biomedical research innovations with the potential to address significant unmet medical needs and building novel therapeutics to bring to the clinic.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/13/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Medical Officer
Carrolee Barlow
Company Investors
- Alexandria Venture Investments
- Avalon BioVentures
- MPM Capital
- Catalys Pacific
- Johnson & Johnson Innovation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs